Cover Image

New Developments in Cystic Fibrosis Airway Inflammation

Saved in:

Bibliographic Details
Main Authors:	Nades Palaniyar (Author), Marcus A. Mall (Author), Christian Taube (Author), Stefan Worgall (Author), Hartmut Grasemann (Author)
Format:	Book
Published:	Hindawi Limited, 2015-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Lipid Mediator Hepoxilin A3 Is a Natural Inducer of Neutrophil Extracellular Traps in Human Neutrophils
by: David N. Douda, et al.
Published: (2015)

Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction
by: Veronica Marcos, et al.
Published: (2015)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
by: Bergin DA, et al.
Published: (2013)

Role of the SLC26A9 Chloride Channel as Disease Modifier and Potential Therapeutic Target in Cystic Fibrosis
by: Anita Balázs, et al.
Published: (2018)

Inflammation in Cystic Fibrosis
Published: (1996)

Airway Epithelium Dysfunction in Cystic Fibrosis and COPD
by: Virginia De Rose, et al.
Published: (2018)

Genetic Deletion and Pharmacological Inhibition of PI3Kγ Reduces Neutrophilic Airway Inflammation and Lung Damage in Mice with Cystic Fibrosis-Like Lung Disease
by: Maria Galluzzo, et al.
Published: (2015)

MDCT-based longitudinal automated airway and air trapping analysis in school-age children with mild cystic fibrosis lung disease
by: Oliver Weinheimer, et al.
Published: (2023)

Airway Inflammatory/Immune Responses in COPD and Cystic Fibrosis
by: Virginia De Rose, et al.
Published: (2018)

The Resolution Approach to Cystic Fibrosis Inflammation
by: Antonio Recchiuti, et al.
Published: (2020)

Three-Dimensional Airway Spheroids and Organoids for Cystic Fibrosis Research
by: Onofrio Laselva, et al.
Published: (2021)

Effects of lumacaftor-ivacaftor therapy on cystic fibrosis transmembrane conductance regulator function in F508del homozygous patients with cystic fibrosis aged 2-11 years
by: Julian Berges, et al.
Published: (2023)

Effects of elexacaftor/tezacaftor/ivacaftor therapy on mental health of patients with cystic fibrosis
by: Linus Piehler, et al.
Published: (2023)

Inflammation and Infection in Cystic Fibrosis: Update for the Clinician
by: Argyri Petrocheilou, et al.
Published: (2022)

Challenges Facing Airway Epithelial Cell-Based Therapy for Cystic Fibrosis
by: Andrew Berical, et al.
Published: (2019)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
by: Maelle Briottet, et al.
Published: (2020)

Mitochondrial Stress Responses and "Mito-Inflammation" in Cystic Fibrosis
by: Simone Patergnani, et al.
Published: (2020)

New Treatment of Cystic Fibrosis
by: article Editorial
Published: (2020)

Inflammation and CFTR: Might Neutrophils be the Key in Cystic Fibrosis?
by: V. Witko-Sarsat, et al.
Published: (1999)

Update of Faecal Markers of Inflammation in Children with Cystic Fibrosis
by: Jung M. Lee, et al.
Published: (2012)

Comparison of Oropharyngeal Microbiota from Children with Asthma and Cystic Fibrosis
by: Sébastien Boutin, et al.
Published: (2017)

Vasculitis in Cystic Fibrosis
by: Francesca Sposito, et al.
Published: (2020)

Assessment of Selected Parameters of Liver Fibrosis and Inflammation in Patients with Diagnosed Cystic Fibrosis
by: Sabina Więcek, et al.
Published: (2020)

Cystic Fibrosis in the Light of New Research
Published: (2015)

Platelets: A Neglected Cell in Cystic Fibrosis Lung Inflammation
by: Ali Özdemir, et al.
Published: (2024)

Esomeprazole Increases Airway Surface Liquid pH in Primary Cystic Fibrosis Epithelial Cells
by: Livia Delpiano, et al.
Published: (2018)

Assessment of the microbial load of airway clearance devices used by a cohort of children with cystic fibrosis
by: B. Linnane, et al.
Published: (2021)

The Cystic Fibrosis Impact Questionnaire: qualitative development and cognitive evaluation of a new patient-reported outcome instrument to assess the life impacts of cystic fibrosis
by: Kelly P. McCarrier, et al.
Published: (2020)

Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021)

Arachidonic Acid and Docosahexaenoic Acid Metabolites in the Airways of Adults With Cystic Fibrosis: Effect of Docosahexaenoic Acid Supplementation
by: Elisabetta Teopompi, et al.
Published: (2019)

Ruthenium(II) Polypyridyl Complexes for Antimicrobial Photodynamic Therapy: Prospects for Application in Cystic Fibrosis Lung Airways
by: Raphaëlle Youf, et al.
Published: (2022)

Vitamin D inhibits pro-inflammatory cytokines in the airways of cystic fibrosis patients infected by Pseudomonas aeruginosa- pilot study
by: M. Olszowiec-Chlebna, et al.
Published: (2019)

Changes of Proteases, Antiproteases, and Pathogens in Cystic Fibrosis Patients' Upper and Lower Airways after IV-Antibiotic Therapy
by: Ulrike Müller, et al.
Published: (2015)

CLINICAL AND FUNCTIONAL EFFECTIVENESS AND SAFETY OF HIGH-FREQUENCY OSCILLATION OF CHEST WITH «THE VEST AIRWAY CLEARANCE SYSTEM» IN CHILDREN WITH CYSTIC FIBROSIS
by: N.Yu. Kashirskaya, et al.
Published: (2010)

CLINICAL AND FUNCTIONAL EFFECTIVENESS AND SAFETY OF HIGH-FREQUENCY OSCILLATION OF CHEST WITH «THE VEST AIRWAY CLEARANCE SYSTEM» IN CHILDREN WITH CYSTIC FIBROSIS
by: N.Yu. Kashirskaya, et al.
Published: (2010)

Supplementation with Red Palm Oil Increases β-Carotene and Vitamin A Blood Levels in Patients with Cystic Fibrosis
by: Olaf Sommerburg, et al.
Published: (2015)

ASTHMA IN CYSTIC FIBROSIS
by: Marcela Daniela Ionescu, et al.
Published: (2015)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016)

The History of Cystic Fibrosis
by: Javier Pérez-Frías, et al.
Published: (2019)

Editorial: New insights into caring for pediatric patients with cystic fibrosis
by: Stephanie Bui, et al.
Published: (2023)